The cost of prescription drugs can take a significant toll on patients and impact their drug adherence and overall health. Primary care providers, historically, have been unable to do much to help patients manage this problem, but recent regulatory changes are adding price transparency which may help. Experts Michael Adelberg and VillageMD’s very own Adam Chesler discuss the details of new transparency initiatives for both Medicare Advantage and commercial drugs and predict the potential impact for patients and providers.
VillageMD’s Working Smarter podcasts are concise healthcare compliance conversations that are never boring and sometimes funny. We provide practical information about complex legal and regulatory topics. Reminder, we have closed captioning and transcripts that are now available for our podcast!
If you enjoy the podcast, we want your help in spreading the word! Share this episode with your friends and colleagues. We are available on Apple, Spotify, any other podcasting apps.